Sun C J, Johannessen J N, Gessner W, Namura I, Singhaniyom W, Brossi A, Chiueh C C
Food and Drug Administration, Bethesda, Maryland.
J Neural Transm. 1988;74(2):75-86. doi: 10.1007/BF01245141.
Unilateral intranigral administration of the oxidative metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 1-methyl-4-phenyl-dihydropyridine (MPDP+) or 1-methyl-4-phenylpyridine (MPP+) produced dose-dependently a depletion of dopamine in the ipsilateral striatum of rats two weeks following treatment. d-Amphetamine and apomorphine induced circling toward the lesioned side in these unilaterally treated animals. No contralateral circling behavior was observed after challenging with apomorphine. This dopamine lesioning effect of MPP+ was not blocked by pretreatment of animals with a dopamine uptake blocker, GBR 12909. Furthermore, MPP+ increased the 45Ca accumulation into cells at the site of injection and produced "nonspecific" cell membrane and/or cytotoxic damage seen by histological procedures. These results indicate that MPDP+ and MPP+ produced localized cytotoxic damage to nigrostriatal neurons, caused a decrease in striatal dopamine, and disrupted the nigrostriatal system's functioning following intranigral administration to rats. It is postulated that the cationic surfactant properties of MPDP+ and MPP+ might contribute to its neurotoxic effects.
在大鼠脑内单侧黑质注射1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)、1-甲基-4-苯基二氢吡啶(MPDP+)或1-甲基-4-苯基吡啶(MPP+)的氧化代谢产物,给药两周后,同侧纹状体中的多巴胺呈剂量依赖性减少。在这些单侧治疗的动物中,右旋苯丙胺和阿扑吗啡诱导动物向损伤侧旋转。用阿扑吗啡激发后未观察到对侧旋转行为。MPP+的这种多巴胺损伤作用不会被多巴胺摄取阻滞剂GBR 12909预处理动物所阻断。此外,MPP+增加了注射部位细胞对45Ca的摄取,并产生了组织学检查所见的“非特异性”细胞膜和/或细胞毒性损伤。这些结果表明,MPDP+和MPP+对黑质纹状体神经元产生局部细胞毒性损伤,导致纹状体多巴胺减少,并在大鼠脑内单侧黑质给药后破坏黑质纹状体系统的功能。据推测,MPDP+和MPP+的阳离子表面活性剂特性可能有助于其神经毒性作用。